Sitemap

For Innovators

Maximize your potential by joining our global network.
Sign In  ●  Create Account

For Companies

Drive growth through innovation.
Learn more

Introducing Arcnet

See how Arcnet will change innovation financing and become the next-generation investment infrastructure.

Find Out More


Innovation Opportunities

Seeking innovative solutions for:

  • Blockchain Innovation ExpertXinova requires a subject matter expert to evaluate a next generation blockchain platform that utilizes a unique chain joining capability between multiple blockchains.
  • Free the WaterXinova is seeking ways to manage the watery dough problem so vegetables can be included into sheets of dough and baked like traditional crackers.
  • View all opportunities

No one company can corner in or create a monopoly on the best thinking that’s out there. And so if we’ve built the lab and we invested a billion dollars in discovering medicines, we can only do what we could in the four walls of our village. But if we if we walk outside of that, we’re fishing in an ocean versus a pond for innovation.

~Allergan CEO Brent Saunders

Allergan Chief Brent Saunders

Allergan Chief Brent Saunders

Clifton Leaf, a Fortune.com Brainstorm Health author highlights an interview his colleague, Sy Mukherjee, did with Allergan CEO Brent Saunders. The article and the original interview bring home the concept that our Xinova business model is based upon – a model that connects our clients with a global network of over 10,000 inventors in a way that augments and achieves what in-house innovation models are unable to do alone. 


The article below has been reposted from Fortune’s Brainstorm Health. 

Good afternoon. Sy has a fascinating interview with Allergan CEO Brent Saunders that went up over the weekend on Fortune.com. If you haven’t seen it, check it out here.

Saunders has been at the forefront of the serial acquisitions and licensing game—and he’s candid about why, in his view, big pharma is better suited to shop for new drugs on the outside rather than try to develop them in-house. “I would say that [drug development] has historically relied on an open science type of approach to innovation,” Saunders says. “But over the course of time, they also built a tremendous and pricey fixed infrastructure to try to discover their own drug candidates. And I think the data would show that, while amazing discoveries have been brought forward for patients in in these large discovery labs, over an extended period of time, they have not been a good investment.”

You may have the most talented and best-funded drug developers on the payroll, he says, but a single pool of talent DNA is going to produce a similar line of product over time. “No one company can corner in or create a monopoly on the best thinking that’s out there,” says Saunders. “And so if we’ve built the lab and we invested a billion dollars in discovering medicines, we can only do what we could in the four walls of our village. But if we if we walk outside of that, we’re fishing in an ocean versus a pond for innovation.”

Some of you out there may think of that as an abdication of the old pharma claim to wonder drug alchemy, surrendering the throne of in-house innovation. But Saunders seems to be interested only in surrendering the old business model, which has been increasingly hard to make work. Bristol’s recent setbacks on the cancer immunotherapy front and Merck and Lilly’s frustrations in drug development for Alzheimer’s are cases in point.

Check out the full interview here.

Clifton Leaf

@CliftonLeaf

clifton.leaf@fortune.com

Would you like to learn more about Xinova? 

Innovators Companies

More from the blog

Connect with Xinova

We are always seeking new problems to solve, as well as innovators and entrepreneurs to help us solve them. Let’s work together to create the future.

Our Worldwide Locations

USA

Xinova
311 ½ Occidental Ave S
Suite 300
Seattle, WA 98104
USA
+1 (206) 800-2678

Japan

Xinova Japan GK
Yaesu Mitsui Building 6F
2-7-2 Yaesu, Chuo-ku
Tokyo 104-0028 Japan
+81-3-6478-6120
xinova.jp

China

Xinova Innovation (Beijing) Consultancy Co. Ltd.
Room 2494, Level 24, Tower 3
China Central Place
77 Jianguo Road
Chaoyang District
Beijing, 100025 China

Singapore

Xinova Asia Pte Ltd.
150 Beach Road
#08-06/08 Gateway West
189720 Singapore
+65 6408 5080

Korea

Xinova Korea
10th floor, Golfzone Tower
735, Yeongdong-daero
Gangnam-gu
Seoul 06072, Korea
+82 2 6952 8840
xinova.co.kr

Australia

Xinova Australasia Pty Ltd.
Level 6, 8 West Street
North Sydney, NSW 2060
Australia
+61 2 8093 4850

India

Xinova India
Suite No 208, 2nd Floor
Survey No 414
PSR Complex
Govinda Reddy (GR) Layout
Bannerghatta Road
Karnataka, 560076, India

Finland

Xinova Finland
Erottajankatu 5 A 4
FI-00130 Helsinki
Finland

Affiliate offices in Tel Aviv & Vienna